Michael Karsch’s Newest Stock Picks:Express Scripts, CVS Caremark, SLM Corp

Karsch Capital Management recently filed its 13F for the second quarter of 2012 with the SEC, allowing reviewers the chance to see a number of the fund’s equity positions. Express Scripts (NASDAQ:ESRX), CVS Caremark (NYSE:CVS), and SLM Corp (NYSE:SLM) are among Michael Karsch’s top stock picks. Much of the fund’s strategy had been discussed on a recent conference call the fund had held to discuss results for the first quarter, helping Insider Monkey look at its holdings and identify investment themes that are being played through Karsch’s large positions. Here are some themes that we see in their second quarter 13F:

Michael Karsch

Express Scripts merger. Karsch continued its strategy of investing in the changing pharmacy benefit management industry. Express Scripts (NASDAQ:ESRX) is set to gain synergies through its merger with Medco Solutions, which in the first quarter had helped it make it onto our list of the ten most popular healthcare stocks among hedge funds. However, as noted in the fund’s Q1 conference call, Karsch also sees the potential for CVS Caremark (NYSE:CVS) to benefit both from consolidation of the pharmacy benefit management industry. During the second quarter the fund slightly reduced its stake in Express Scripts but increased its position in CVS.

Cash to shareholders. Another factor that was mentioned on the conference call as something that the fund looks for is the returning of cash to shareholders, generally through repurchases of shares. Two of the companies that were mentioned in the call on this point were Viacom (NASDAQ:VIA.B) and SLM (NASDAQ:SLM), and over the course of the second quarter Karsch expanded these positions. The fund closed June with about 3 million shares of Viacom, up from 2.2 million shares three months earlier, and its 2.8 million share position in SLM became 4.4 million shares. These companies don’t particularly have much in common- Viacom being a mega media conglomerate and SLM managing education loans- but they do have a good record of repurchases and plenty of cash on hand. SLM is also cheap on a value basis, with a trailing P/E of 10, a forward P/E of 7, and a 3.1% dividend yield.

Tyco. Karsch more than doubled its position in Tyco (NYSE:TYC), bringing the fund’s position from 1 million to 2.6 million shares. According to the 13F filing, it is now the second largest position in the portfolio by market value. The security and fire protection systems company has seen earnings fall in its most recent quarter compared to the same period in the previous year. However, sell-side analysts believe that the stock will recover and deliver growth next year: it trades at a multiple of 14 times 2013 earnings, and 20 times trailing earnings.

eBay. We already covered Karsch’s interest in eBay last month, before we knew that the fund had been so interested in the stock that it had increased its position from 1 million to 1.7 million shares over the course of the second quarter. eBay (NASDAQ:EBAY) has been doing particularly well in its Payments segment, which includes the Paypal business, as it has seen good growth in revenue and earnings. However the company trades at 16 times trailing earnings- not sufficient enough to recommend the stock on a purely value basis, but there is a good deal of industry related potential.

There weren’t a lot of surprises in Karsch’s filing. The fund stuck to its guns on its bullish position in eBay (NASDAQ:EBAY) and on its tactics of engaging with pharmacy benefit management companies and seeking out companies looking to return cash to shareholders. Investors can therefore pick and choose which (if any) of these themes it makes sense to copy and then pursue Karsch’s own choice of instrument accordingly.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Cheapest Cities to Visit in the US

Most Expensive Summer Camps

Most Expensive Animals in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!